144 related articles for article (PubMed ID: 34976603)
1. Hepatitis C identification and treatment in rural Pennsylvania, USA.
Stainbrook T; Elliott K; Powell A; Simpson MA; Bash M
Prev Med Rep; 2021 Dec; 24():101526. PubMed ID: 34976603
[TBL] [Abstract][Full Text] [Related]
2. Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic.
Fraser H; Zibbell J; Hoerger T; Hariri S; Vellozzi C; Martin NK; Kral AH; Hickman M; Ward JW; Vickerman P
Addiction; 2018 Jan; 113(1):173-182. PubMed ID: 28734093
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.
Barbosa C; Fraser H; Hoerger TJ; Leib A; Havens JR; Young A; Kral A; Page K; Evans J; Zibbell J; Hariri S; Vellozzi C; Nerlander L; Ward JW; Vickerman P
Addiction; 2019 Dec; 114(12):2267-2278. PubMed ID: 31307116
[TBL] [Abstract][Full Text] [Related]
4. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
5. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
[TBL] [Abstract][Full Text] [Related]
7. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
[TBL] [Abstract][Full Text] [Related]
8. A Regional Analysis of Hepatitis C Virus Collaborative Care With Pharmacists in Indian Health Service Facilities.
Geiger R; Steinert J; McElwee G; Carver J; Montanez R; Niewoehner J; Clark C; Reilley B
J Prim Care Community Health; 2018; 9():2150132718807520. PubMed ID: 30348039
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.
Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL
Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493
[TBL] [Abstract][Full Text] [Related]
10. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
[TBL] [Abstract][Full Text] [Related]
11. Screening for Hepatitis C Virus Infection in Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Chou R; Dana T; Fu R; Zakher B; Wagner J; Ramirez S; Grusing S; Jou JH
JAMA; 2020 Mar; ():. PubMed ID: 32119034
[TBL] [Abstract][Full Text] [Related]
12. Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison.
Fraser H; Vellozzi C; Hoerger TJ; Evans JL; Kral AH; Havens J; Young AM; Stone J; Handanagic S; Hariri S; Barbosa C; Hickman M; Leib A; Martin NK; Nerlander L; Raymond HF; Page K; Zibbell J; Ward JW; Vickerman P
Am J Epidemiol; 2019 Aug; 188(8):1539-1551. PubMed ID: 31150044
[TBL] [Abstract][Full Text] [Related]
13. Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection.
Lodi S; Klein M; Rauch A; Epstein R; Wittkop L; Logan R; Rentsch CT; Justice AC; Touloumi G; Berenguer J; Jarrin I; Egger M; Puoti M; D'Arminio Monforte A; Gill J; Salmon Ceron D; van Sighem A; Linas B; van der Valk M; Hernán MA;
J Int AIDS Soc; 2022 Dec; 25(12):e26048. PubMed ID: 36562643
[TBL] [Abstract][Full Text] [Related]
14. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care.
Bushman ET; Subramani L; Sanjanwala A; Dionne-Odom J; Franco R; Owen J; Subramaniam A
Am J Perinatol; 2021 Sep; 38(11):1109-1116. PubMed ID: 33934324
[TBL] [Abstract][Full Text] [Related]
15. Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.
Walter LA; Wilson L; Farmer M; Roberson T; Hand DT; Franco R
Am J Emerg Med; 2023 Oct; 72():178-182. PubMed ID: 37540919
[TBL] [Abstract][Full Text] [Related]
16. Cascade of Care for Hepatitis C Virus Infection Among Young Adults Who Inject Drugs in a Rural County in New Mexico.
Carmody MD; Wagner K; Bizstray B; Thornton K; Fiuty P; Rosario AD; Teshale E; Page K
Public Health Rep; 2023; 138(6):936-943. PubMed ID: 36633367
[TBL] [Abstract][Full Text] [Related]
17. Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).
Fadnes LT; Aas CF; Vold JH; Leiva RA; Ohldieck C; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA;
PLoS Med; 2021 Jun; 18(6):e1003653. PubMed ID: 34061883
[TBL] [Abstract][Full Text] [Related]
18. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
Lebovics E; Torres R; Porter LK
Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model.
Dhiman RK; Grover GS; Premkumar M; Roy A; Taneja S; Duseja A; Arora S;
EClinicalMedicine; 2021 Nov; 41():101148. PubMed ID: 34712928
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
